Gilead Sciences
Patents, Design & Utilities
Last updated:
List of all Gilead Sciences patents 302 in total
| Status | Patent |
|---|---|
Grant | Utility: Modulators of toll-like receptors Filling date: 6 Sep 2025 Issue date: 7 Sep 2021 |
Grant | Utility: Apoptosis signal-regulating kinase inhibitors Filling date: 6 Sep 2025 Issue date: 31 Aug 2021 |
Grant | Utility: Therapeutic heterocyclic compounds Filling date: 6 Sep 2025 Issue date: 24 Aug 2021 |
Application | Utility: 2'- SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT Filling date: 6 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: SUBSTITUTED PYRROLIZINE COMPOUNDS AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 19 Aug 2021 |
Grant | Utility: Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use Filling date: 6 Sep 2025 Issue date: 10 Aug 2021 |
Grant | Utility: HIV inhibitor compounds Filling date: 6 Sep 2025 Issue date: 3 Aug 2021 |
Grant | Utility: Solid forms of a toll-like receptor modulator Filling date: 6 Sep 2025 Issue date: 27 Jul 2021 |
Grant | Utility: Substituted 6-azabenzimidazole compounds Filling date: 6 Sep 2025 Issue date: 27 Jul 2021 |
Grant | Utility: Cot modulators and methods of use thereof Filling date: 6 Sep 2025 Issue date: 20 Jul 2021 |
Application | Utility: PYRROLO[1,2-b]PYRIDAZINE DERIVATIVES Filling date: 6 Sep 2025 Issue date: 15 Jul 2021 |
Grant | Utility: Pyrrolo[1,2-b]pyridazine derivatives Filling date: 6 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Anti-HIV compounds Filling date: 6 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Thiadiazole IRAK4 compounds Filling date: 6 Sep 2025 Issue date: 29 Jun 2021 |
Application | Utility: CAPSID INHIBITORS FOR THE PREVENTION OF HIV Filling date: 6 Sep 2025 Issue date: 24 Jun 2021 |
Grant | Utility: Therapeutic heterocyclic compounds Filling date: 6 Sep 2025 Issue date: 22 Jun 2021 |
Application | Utility: PROCESSES AND INTERMEDIATES FOR PREPARING MCL1 INHIBITORS Filling date: 6 Sep 2025 Issue date: 17 Jun 2021 |
Grant | Utility: Compounds for the treatment of HIV Filling date: 6 Sep 2025 Issue date: 15 Jun 2021 |
Application | Utility: TRIAZOLE CARBAMATE PYRIDYL SULFONAMIDES AS LPA RECEPTOR ANTAGONISTS AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: MCL1 INHIBITORS Filling date: 6 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: GLP-1R MODULATING COMPOUNDS Filling date: 6 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: THERAPEUTIC COMPOUNDS Filling date: 6 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: CRYSTALLINE FORMS OF (S)-2-ETHYLBUTYL 2-(((S)-(((2R,3S,4R,5R)-5- (4-AMINOPYRROLO[2,1-F] [1,2,4]TRIAZIN-7-YL)-5-CYANO-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL)METHOXY) (PHENOXY) PHOSPHORYL)AMINO)PROPANOATE Filling date: 6 Sep 2025 Issue date: 3 Jun 2021 |
Grant | Utility: Phosphatidylinositol 3-kinase inhibitors Filling date: 6 Sep 2025 Issue date: 1 Jun 2021 |
Application | Utility: HUMAN IMMUNODEFICIENCY VIRUS NEUTRALIZING ANTIBODIES Filling date: 6 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: TLR-9 AGONISTS FOR MODULATION OF TUMOR MICROENVIRONMENT Filling date: 6 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: COT MODULATORS AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: SUBSTITUTED PYRROLIZINE COMPOUNDS AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 20 May 2021 |
Grant | Utility: Methods for treating arenaviridae and coronaviridae virus infections Filling date: 6 Sep 2025 Issue date: 18 May 2021 |
Application | Utility: ANTIBODIES AND FRAGMENTS THEREOF THAT BIND HEPATITIS B VIRUS PROTEIN X Filling date: 6 Sep 2025 Issue date: 29 Apr 2021 |
Grant | Utility: MCL-1 inhibitors Filling date: 6 Sep 2025 Issue date: 27 Apr 2021 |
Grant | Utility: Processes and intermediates for the preparation of 1'-substituted carba-nucleoside analogs Filling date: 6 Sep 2025 Issue date: 27 Apr 2021 |
Application | Utility: SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 22 Apr 2021 |
Grant | Utility: FXR (NR1H4) modulating compounds Filling date: 6 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Combination therapy comprising an ACC inhibitor Filling date: 6 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Synthesis of polycyclic-carbamoylpyridone compounds Filling date: 6 Sep 2025 Issue date: 13 Apr 2021 |
Application | Utility: HBV VACCINES AND METHODS TREATING HBV Filling date: 6 Sep 2025 Issue date: 1 Apr 2021 |
Application | Utility: HIV PROTEASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: THERAPEUTIC COMPOUNDS Filling date: 6 Sep 2025 Issue date: 18 Mar 2021 |
Grant | Utility: Cot modulators and methods of use thereof Filling date: 6 Sep 2025 Issue date: 16 Mar 2021 |
Grant | Utility: Solid forms of an ASK1 inhibitor Filling date: 6 Sep 2025 Issue date: 16 Mar 2021 |
Application | Utility: FLT3L-Fc FUSION PROTEINS AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 11 Mar 2021 |
Grant | Utility: 2'-substituted carba-nucleoside analogs for antiviral treatment Filling date: 6 Sep 2025 Issue date: 9 Mar 2021 |
Grant | Utility: Method of purifying an antibody Filling date: 6 Sep 2025 Issue date: 9 Mar 2021 |
Application | Utility: COT MODULATORS AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: METHODS AND COMPOUNDS FOR TREATING PARAMYXOVIRIDAE VIRUS INFECTIONS Filling date: 6 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: COMPOUNDS FOR INHIBITION OF ALPHA 4 BETA 7 INTEGRIN Filling date: 6 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: THIENOPYRIMIDINE DERIVATIVES AS ACC INHIBITORS AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: THERAPEUTIC COMPOSITIONS FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS Filling date: 6 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: PD-1/PD-L1 INHIBITORS Filling date: 6 Sep 2025 Issue date: 25 Feb 2021 |
Showing 100 to 150 of 302 patents.